DecisionMap Wealth Management’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$627K Sell
24,903
-268
-1% -$6.75K 0.35% 67
2026
Q1
$636K Buy
25,171
+12,080
+92% +$308K 0.41% 66
2025
Q4
$334K Buy
13,091
+4,994
+62% +$128K 0.21% 96
2025
Q3
$207K Buy
+8,097
New +$205K 0.13% 121

Other funds holding IBDX

DecisionMap Wealth Management's IBDX Position: Q2 2026 in Review

DecisionMap Wealth Management reduced its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 1.1% in Q2 2026, selling an estimated $6.75K and leaving 24,903 shares worth $627K. The position accounts for 0.35% of the portfolio, ranked #67.

DecisionMap Wealth Management first reported a position in IBDX in Q3 2025 and has held it in 4 quarters since. The position peaked at $636K in Q1 2026. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • DecisionMap Wealth Management held 24,903 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $627K as of Q2 2026.
  • DecisionMap Wealth Management sold 268 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $6.75K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.35% of DecisionMap Wealth Management's portfolio in Q2 2026, its #67 holding.
  • DecisionMap Wealth Management first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2025 and has held it in 4 quarters since.
  • DecisionMap Wealth Management's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $636K in Q1 2026.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on DecisionMap Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.